Literature DB >> 3336463

Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease.

L A Hansen1, R DeTeresa, P Davies, R D Terry.   

Abstract

We studied neocortical morphometry (cortical thickness, neurons, and glia), lesion counts (plaques and tangles), and choline acetyltransferase levels in up to 113 Alzheimer brains and 48 controls. Comparisons between young (under 65) and old (over 70) Alzheimer cases revealed more tangles in the former, but no other statistically significant differences in the measured variables. Differences in these parameters between young Alzheimer cases and young controls were similar to the differences found between old Alzheimer cases and old controls. Linear regression analyses correlating some of these variables with age in Alzheimer's disease, considered together with the effects of normal aging on the same parameters, reveal in Alzheimer's disease a spectrum of graded pathologic severity inversely proportional to age. Nevertheless, even in advanced old age (80 to 100), significant differences persist in these parameters between very elderly Alzheimer brains and controls.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336463     DOI: 10.1212/wnl.38.1.48

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Alzheimer disease: AD pathology--emerging subtypes or age-of-onset spectrum?

Authors:  Eliezer Masliah; Lawrence A Hansen
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Size of neocortical neurons in control subjects and in Alzheimer's disease.

Authors:  M J Bundgaard; L Regeur; H J Gundersen; B Pakkenberg
Journal:  J Anat       Date:  2001-04       Impact factor: 2.610

Review 3.  Changes in the ageing brain in health and disease.

Authors:  B H Anderton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

4.  Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.

Authors:  S Flament; A Delacourte; P Delaère; C Duyckaerts; J J Hauw
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.

Authors:  A Delacourte; S Flament; E M Dibe; P Hublau; B Sablonnière; B Hémon; V Shérrer; A Défossez
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

Review 7.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

8.  Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease.

Authors:  E Salmon; F Collette; C Degueldre; C Lemaire; G Franck
Journal:  Hum Brain Mapp       Date:  2000-05       Impact factor: 5.038

9.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

10.  Cortical Lewy body-containing neurons are pyramidal cells: laser confocal imaging of double-immunolabeled sections with anti-ubiquitin and SMI32.

Authors:  K Wakabayashi; L A Hansen; E Masliah
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.